Moderna Hit With Another Lawsuit Related To Key COVID-19 Vaccine Technology - Moderna ( NASDAQ:MRNA )
Northwestern University has filed a patent infringement lawsuit against Moderna, Inc. MRNA, alleging the pharmaceutical company used the university's lipid nanoparticle ( LNP ) technology without permission to develop its COVID-19 vaccines.
| Ticker |
Sentiment |
Impact |
|
MRNA
|
Neutral
|
60 %
|
|
GSK
|
Neutral
|
32 %
|
|
PFE
|
Neutral
|
25 %
|
|
BNTX
|
Neutral
|
17 %
|
